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ABSTRACT  Synapsin  I (protein  I)  is a major  neuron-specific endogenous substrate for cAMP- 
dependent and Ca/calmodulin-dependent  protein kinases that is widely distributed in synapses 
of the central  and peripheral  nervous system  (De Camilli,  P., R. Cameron,  and  P. Greengard, 
1983, J. Cell Biol. 96:1337-1354). We have now carried  out a detailed analysis of the ultrastruc- 
tural  localization  of synapsin  I in the synapse.  For this purpose we have  developed  a novel 
immunocytochemical  technique that involves the labeling of isolated synaptosomes  immobi- 
lized in a thin agarose gel. Special fixation conditions were designed to maximize accessibility 
of  synapsin  I  to  marker  molecules.  Immunoferritin  and  immunoperoxidase  studies  of  this 
preparation indicated that synapsin I is localized in the presynaptic compartment and that it is 
present in close to 100% of all nerve endings. Immunoferritin labeling also indicated that, inside 
the nerve ending, synapsin I is specifically associated with the cytoplasmic surface of synaptic 
vesicles.  In agreement with these  immunoferritin  results, the labeling  produced  by immuno- 
peroxidase  was  compatible  with  a  specific  association  of  synapsin  I  with  synaptic  vesicle 
membranes.  However,  at  variance  with  the  very  specific  distribution  of  immunoferritin, 
immunoperoxidase  reaction  product  was  also  found  on  other membranes  of  the terminals, 
presumably as a result of its diffusion over a short distance from the synaptic vesicles. 
Anti-synapsin I immunoperoxidase staining of tissue  sections for electron  microscopy pro- 
duced an uneven labeling of terminals of the neuropile, in agreement  with results of a previous 
study (Bloom, F. E., T. Ueda,  E. Battenberg,  and  P. Greengard,  1979, Proc.  Natl. Acad. Sci. USA. 
76:5982-5986).  A  comparison  with  results  obtained  in  isolated  synapses  indicates  that  the 
limited labeling of nerve endings in tissue sections results from limited and uneven penetration 
by marker molecules. 
The specific association of synapsin I with synaptic vesicle  membranes  in the great  majority 
of  nerve  terminals  suggests  a  prominent  role  for  this  phosphoprotein  in  the  regulation  of 
synaptic vesicle function. 
Synapsin I, previously referred to as protein I  (8),  is a  major 
neuron-specific  substrate  for  cAMP-dependent  and  Ca/cal- 
modulin-dependent protein kinases (18,  19, 21, 23, 25, 35, 38). 
It is present  in  high  concentration  in  the  mammalian brain 
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(13). Immunocytochemical studies carried out by an immuno- 
peroxidase technique (2, 9), and more recently by imrnunoflu- 
orescence (8), have indicated that synapsin I  is a  nerve cell- 
specific protein that is highly concentrated at synapses and has 
1355 a  very  widespread  distribution  throughout  the  central  and 
peripheral nervous systems. In fact, it seems to be present at 
the great majority of synapses. 
The present study was undertaken to confirm at the electron 
microscopic  level  this  general  distribution  of synapsin  I  at 
synapses, and to identify, at the ultrastructural level,  the local- 
ization of protein I in the synapse. For this purpose, we have 
developed  a  novel  immunocytochemical technique  that  in- 
volves the immunolabeling,  by immunoferritin  or by immu- 
noperoxidase,  of synaptosomes  embedded  in  agarose.  This 
procedure  has  been  specifically designed to overcome those 
technical problems that affect immunocytochemical studies in 
fixed  intact  tissues.  Our  results  indicate  that  synapsin  I  is 
present in the presynaptic compartment, where it is primarily 
associated with the cytoplasmic side of synaptic vesicle mem- 
branes.  These studies also demonstrate conclusively that syn- 
apsin I is present at the great majority of synapses. 
MATERIALS  AND  METHODS 
Sprague-Dawley rats weighing 150--200 gm were obtained from Charles River 
Breeding Laboratories, Wilmington, MA; cyanogen-bromide-activated Sepha- 
rose 4B and agarose C were from Pliarmacia (Uppsala, Sweden);  Triton X-100, 
sapomn, chicken egg albumin, bovine serum albumin (fraction V), ferritin (from 
horse spleen), and 3,Y-diaminobenzidine tetra-HC1  were from Sigma Chemical 
Co. (St. Louis, MO); paraformaldehyde, glutaraldehyde (10% aqueous solution) 
and OsO4 (4% aqueous solution) were from Electron Microscopy Sciences (Fort 
Washington, PA); sucrose was from Schwartz Mann (Orangeburg, NY); H~Oz 
(30% vol/vol aqueous solution) was from Eastman Kodak Co. (Rochester, NY). 
Purified synapsin I, used for atTmity purification of ami-synapsin I antibodies, 
was the girl of Dr. Louis J. DeGennaro. 
ANTIBODIES:  All antiserum directed  against synapsin I  was prepared as 
described (8) by injecting rabbits with synapsin I (synapsin la and synapsin Ib) 
that  had been pnrified from bovine brain by a  procedure involving SDS gel 
electrophoresis  as  the  final  step.  The  specificity  of the  antiserum  has  been 
extensively  characterized  (8).  Rabbit antibodies specific  for synapsin I  (anti- 
synapsin I IgG [Rb])  l were purified from the serum by affinity-chromatography 
(7,  ll) on a  synapsin I-Sepliarosc-4B column. Horseradish peroxidase--conju- 
gated goat antibodies specific  for rabbit IgGs (HRP-antilgG  [G vs. Rb]) were 
purified from a commercial (lot 14394; N. L. Cappel Laboratories, Inc., Coch- 
ranviUe, PA) peroxidase-conjugated IgG fraction on a rabbit IgG-Sepharose--4B 
column. In both cases, specific antibodies were etuted from insolub'flized antigens 
by low pH buffer (glycine-HCl buffer, pH 2.3).  Nonimmune rabbit and goat 
IgGs (control IgG [Rb] and control IgG[GI, respectively)  and ferritin-conjugated 
goat IgGs directed against rabbit IgGs (F-anti-IgG [G vs. Rb]) were from Cappel. 
To establish the number of ferritin  particles present on each IgG-ferritin 
conjugate,  a  drop  of very dilute  solution of conjugated  IgGs in  phosphate- 
buffered saline comaining 10  -s M  bovine serum albumin was deposited on a 
Formvar-coated grid.  After 30  s, the grid was blotted  and dried.  Subsequent 
analysis of the grid at the electron microscope revealed that the large majority of 
ferritin  particles occurred as individual  particles  clearly  separated from each 
other. This indicated that the large majority of IgG conjugates contained only 
one ferritin/molecule. 
gently removed, transferred to four new tubes and centrifuged at 12,500 g.v for 
20 rain at 4°C in the same rotor. The resulting pellets were resuspended m  a 
small volume of 0.3 M sucrose, pooled, and referred to as the crude synaptosomal 
fraction. This contained mostly synaptosomes, free mitochondria, and myelin 
fragments. Synaptosomes were not further purified because contaminating or- 
ganelles provided an internal control for evaluating the specificity  of the immu- 
nocytochemical staining procedure. 
Extraction of 5ynapsin I from the Synaptosomes 
A 200-#1 aliquot of the resuspended crude synaptosomal fraction was diluted 
at 0°C in 9 ml of a solution containing 0.15 M KCI and 0.01% (wt/vol) saponin 
(31). After a 5-rain incubation on ice, the sample was centrifuged at 12,500 gay for 
20 rain in a 50Ti rotor (Beckman Instruments, Inc., Spinco Div., Palo Alto, CA) 
at 4°C. The supernatant was discarded and the pellet was resuspended in 1()0  #1 
of 0.3 M sucrose with a Teflon rod. The suspension obtained was then fixed by 
adding 25 #1 of fivefold-concentrated fixative as described for the type A fixation 
(see below). 
Fixation of the Crude Synaptosomal  Fraction 
In all  cases the fmal fixative  solution contained  3% formaldehyde (freshly 
prepared  from paraformaldehyde  [12]), 0.5%  glutaraldehyde,  5  mM  sodium 
phosphate  buffer  (pH  7.4)  (PB).  Sucrose  was  present  at  the  concentration 
indicated for the different fixation protocols. This fixative  solution was selected 
to optlmiTe  labeling of synapsin I  and to preserve its subcellular localization. 
Thus, the higher concentration of formaldehyde than of glutaraidehyd¢  was 
aimed at  reducing the extent of cross-linking of cytoplasmic proteins (which 
would reduce accessthility of synapsin I) as well as minimizing loss of antigenicity 
of synapsin I. The low ionic strength buffer was used to prevent solubilization of 
synapsin I from its subcellular binding sites (20). 
FIXATION  IN NONLYTIC CONDITIONS:  Type A fixation:  Aliquots of the 
crude  synaptosomal fraction  were  rapidly  mixed  with 0.25  vol  of ice-cold, 
flvefold-concentrated fixative.  Synaptosomes were then kept in the fixative  on 
ice  for  30  rain,  after  which they  were  agarose-embedded.  Type B  fixation: 
Aliquots of the crude synaptosomal fraction were fixed by addition of a large 
volume (20 vol) of ice-cold  (1  x) fixative  solution, comaining 0.3  M  sucrose. 
Subcellular particles were then recovered from the suspension by centrifugation 
(12,500 g,, for 20 rain) in a  Beckman 50Ti  rotor at 4°C. Finally, the pelleted 
particles were resuspended in 0.12 M PB by scraping the compact pellet from the 
bottom of the tube with a Teflon rod, homogeniTing the fragments of the pellet 
in a small glass-Teflon homogenizer, and fmaUy passing this suspension several 
times through a 25-gauge needle.  These resuspended particles  were then used for 
agarose embedding. The majority of nerve endings of synaptosomal preparations 
fixed  under these conditions appeared  to have  a  continuous, sealed  plasma 
membrane. Postfixation treatments were, therefore, performed in some experi- 
ments in an effort to make all plasma membranes permeable to macromolecules. 
These treatments included:  (a) cycles of freeze-thawing of the fixed synaptosomal 
suspension (aliquots of the suspension were frozen by immersion in a dry-ice/ 
isopropanol mixture and rapidly thawed in water at room temperature [RT]) and 
(b) detergent treatments of the subcellular particles after agarose embedding (see 
below). 
FIXATION IN LYTIC CONDITIONS:  Aliquots of the crude synaptosomal 
fraction were mixed with 20 vol of ice-cold  (1 x) fixative solution, which did not 
contain sucrose. The diluted subc~llular particles were then recovered by centrif- 
ugation, and resuspended in PB, as described above for the type B fixation. 
Preparation  of a Crude 5ynaptosomal Fraction 
A crude synaptosomal fraction was prepared by minor modifications of the 
method of Gray and Whittaker  (15).  Three rats were killed  by decapitation. 
Brains (including brain stems and cerebella)  were quickly removed and homog- 
enized in 10 vol of ice-cold 0.3 M sucrose by nine strokes at ~900 rpm in a glass/ 
Teflon homogenizer (0.10~1.15 mm clearance).  The homogenate was then divided 
among four tubes and cemrifuged at  1,000 g,v for 10 nun at 4°C in a Sorvall 
centrifuge (SS-34  rotor, DuPont Co., New'town,  CT).  The supernatants were 
1Abbreviations  used  in  this  paper:  F-anti-IgG  (G  vs.  Rb),  ferritin- 
conjugated goat IgGs directed against rabbit IgGs; HRP-anti-IgG (G 
vs. Rb), horseradish peroxidase--conjugated goat IgGs directed against 
rabbit  IgGs; control IgG (G) and control IgG (Rb), goat and rabbit 
nonimmune IgGs, respectively; anti-synapsin I IgG (Rb), rabbit IgGs 
directed  against  synapsin  I;  EM,  electron  microscopy;  PB,  sodium 
phosphate buffer, pH 7.4; RT, room temperature. 
Embedding in Agarose 
Aliquots (180 #l) of fixed synaptosomes were added to tubes immersed in a 
54°C water bath. After a 15-s  interval,  which allowed the suspension to warm up, 
180 vl of a solution (at 54°C) containing 3% agarose in 5 mM PB was added to 
the synaptosomal suspension. The suspension obtained was quickly mixed, while 
still  immersed in the warm water bath, by forcing it up and down through a 
pasteur pipette prewarmed in a 60°C oven. Care was taken to prevent foaming. 
Immediately afterwards, the agarose-synaptosome suspension was transferred by 
pipetting into a frame made from two glass slides separated at each end by two 
coverslips  (0.17 nun thick)  and held together by binding clips as shown in Fig. 
I a. The frame had also been prewarmed in a 60°C oven. The agarose mixture 
was then aUowed to cool and solidify.  At this point, the two glass slides  were 
separated and the agarose gel, attached to one of the glass slides, was cut into 2- 
ram squares with a razorblade. The gel squares were then washed off the glass 
slide into a petri dish (Fig. 1  b) by a stream from a pasteur pipette titled with 0.12 
M  PB.  These agarose squares (agarose blocks) were then transferred to glass 
tubes and used for immunolabeling. 
1356  THE JOURNAL OF CELL BIOLOGY, VOLUME 96, 1983 FIGURE  1  Preparation of agarose blocks  containing  synaptosomes.  (a)  Synaptosome-agarose suspension  being  poured  from  a 
Pasteur pipette into a frame made of two glass slides separated by two coverslips. The two coverslips are indicated by arrows. (b) 
Agarose blocks  containing  synaptosomes suspended  in  buffer  in  a  petri  dish.  The  blocks  were  prepared  by cutting  into small 
squares the agarose gel obtained from the frame shown in  a. Bar, 1 cm. 
Immunoferritin and Immunoperoxidase 
Labeling of Agarose-embedded 
Subcellular Particles 
Agarose blocks containing fixed synaptosomes were sequentially processed 
through the steps described below. All steps were carried out at RT, except where 
indicated, in 12 ×  75 mm glass tubes that contained six agarose blocks each. To 
remove possible protein aggregates, all protein-containing solutions were spun 
for 4 rain in an Eppendorf microfuge (model 5412 Brinkmann instr., Westbury, 
NY.)  before use.  Step 1:  Incubation (30 min) in Tris-HC1 buffer (pH  7.4)  to 
quench unreacted aldehyde groups. Step 2:  Incubation (30 min) in solution A 
(0.5 M  NaC1, 0.02 M  PB, 50 mg/ml chicken egg albumin, and  l mg/ml control 
IgG (G). The purpose of this incubation was to saturate the nonspecific binding 
sites for proteins and in particular for IgGs. Step 3: Incubation (overnight at 4°C) 
in 200/LI of solution A containing anti-synapsin I lgG (Rb) (70-120 #g/ml) or 
control IgG (Rb) (70-120 ~g/ml). Step 4: Washing by incubation in solution B 
(0.5 M NaC1, 0.02 M  PB) with five changes of ~2 ml each over a 90-rain period. 
Step 5: Incubation (120 min) in 200 #1 of solution A containing F- or HRP-anti- 
IgG ((3  vs.  Rb).  The  commercial F-anti-IgG (G  vs.  Rb) was used at a  1:15 
dilution. The affinity purified HRP-anti-lgG (G  vs.  Rb) was used at an IgG 
concentration of ~10-50 ~g/ml. Step 6: Washing in solution B as in step 4. Step 
7: Fixation of the bound antibodies with 1% glutaraldehyde in 0.12 M  PB for 30 
rain. Step 8: washing in 0.12 M  PB.  Agarose blocks labeled by immunoferritin 
were then processed for electron microscopy (EM) as described below. Blocks 
labeled by immunoperoxidase were rinsed in 0.12 M NH4-phosphate buffer (Dr. 
J. Boyles, personal communication) with two changes of 2 ml, 5 rain each and 
then immersed in 1 ml of the same buffer (ice-cold) containing 0.5 mg/ml 3,3'- 
diaminobenzidine tetra-HC1. The latter solution was passed through a Miltipore 
filter (0.22-p.m  mesh) just before use.  The  peroxidase enzymatic reaction was 
carried out on ice and started by the addition of concentrated H~O2 to a  final 
concentration of 0.003% (vol/vol). After 10-15 min, the reaction was terminated 
by dilution with 4 ml of ammonium phosphate buffer followed by several rapid 
changes of the same buffer. Blocks were then processed for EM. 
In some experiments, a detergent treatment (45 rain at room temperature in 
solution B containing either saponin [31] [0.01-0.5%  (wt/vol)] or Triton X-100 
[0.3-1%  (wl/vol)]), aimed at permeabilizing plasma membranes of sealed nerve 
endings, was performed between steps I  and 2. 
Test for Accessibility of Synaptosomes to 
Ferritin Particles 
To test for the ability of unconjugated ferritm to penetrate into fLxed agarose- 
embedded nerve endings, the following procedure was used. Between step 1 and 
step 2 of the immunolabeling  procedure, agarose blocks containing synaptosomes 
were incubated for 90 min at RT in solution B containing 100 mR/m1 unconju- 
gated ferritin. This incubation was directly followed by fLxation in 1% glutaral- 
dehyde in 0.12 M  PB for 30 min at room temperature. Blocks were then washed 
in PB and processed for EM. 
Immunoperoxidase Labeling of Frozen Sections 
of Rat Brain 
Rat brains were fixed by perfusion (3% formaldehyde, 0.5% glutaraMehyde, 
0.12 M PB) and frozen as described (8). Thick frozen sections (20 van thick) were 
cut in a Damon IEC Minotome cryostat (International Equipment Corp., Damon 
Corp.,  Needham  Heights, MA) and the sections were immediately thawed by 
floating them on 0.12 M PB at room temperature in a Petri dish. These sections 
were then processed for synapsin I immunoreactivity  by the same immunoperox- 
idase procedure used for the agarose blocks, and subsequently processed for EM. 
In some cases a 45-rain incubation in solution B containing 0.3% (wt/vol) Triton 
X-100 or saponin (0.01% or 0.5% [wt/vol]) preceded the immunostaining. 
Electron Microscopy 
Agarose blocks were washed with 0.1  M veronal/acetate buffer (pH 7.4) and 
postfixed for I h in 1% OsO4 in the same buffer at 0°C. Then, after a quick rinse 
in veronal/acetate buffer, they were dehydrated in a  graded series of ethanols 
and propylene oxide and embedded in Epon 812 (26). 
Thin sections (silver)  were cut on a Sorvall Porter-Blum MT2 ultra-microtome, 
stained with uranyl  acetate and  lead  citrate and  examined in  a  Philips 301 
electron microscope operated at 80 kV. 
Morphometric Analysis 
Thin ultramicrotome sections of similar thickness (as assessed by their inter- 
ference color) were selected for the various comparisons. 
COUNTS OF SYNAPTIC  VESICLES AND FERRITIN PARTICLES  IN NERVE 
ENDINGS;  Electron micrographs were taken at random until a sample of 100 
nerve endings was reached for each experimental condition. The magnification 
of the EM negatives was x  19,000 or 25,000 and of the final printed mierographs 
was x  65,000. The nerve ending of each synaptosome was examined for the total 
number of vesicles, the total number of ferritin particles, and,  in the case of 
synaptosomes fLxed in nonlytic conditions, the cross-sectional area, which was 
corrected  for  the  fractional  area  occupied  by  mitochondria  or  by  vesicular 
compartments other than synaptic vesicles. Areas were measured with a  Leitz 
planimeter (E. Leitz, Inc., Rocldgigh, N J). To determine areas when interruptions 
were present in the plasma membrane, the free edges of the membrane were 
joined with the  shortest line that included in the  nerve ending space all the 
vesicles that appeared to be part of that ending. 
The following ratios were calculated for each terminal: (a) total number of 
ferritin  particles/total number  of synaptic vesicles, and  (b)  total number  of 
vesicles/cross-sectional  area in tam  2 of the terminal. 
COUNTS OF FERRITIN PARTICLES ON POSTSYNAPTIC DENSITIES (P S O S): 
Electron micrographs of synaptosomes fixed in nonlytic conditions and labeled 
with control  IgG  (Rb)  or  anti-synapsin I  IgG  (Rb)  were  taken at  random 
(magnifications as above). Only PSDs dearly not enclosed by a sealed postsyn- 
aptic plasma membrane were chosen. A line was drawn parallel to the junctional 
postsynaptic plasma membrane at its cytoplasmic side at a distance of ~900 
from its cytoplasmic  leaflet. 900/~ was found to be a sufficient distance to include 
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each PSD we determined: (a) the length of the junctional postsynaptic plasma 
membrane visible in the plane of the section, and (b) the number of ferritin 
particles enclosed between the plasma membrane and the parallel line we had 
drawn. 
We scored PSDs until we reached a  total PSD length of 16.5 pan for both 
groups of samples (~50 PSDs for each sample). 
PERCENTAGES OF NERVE ENDINGS  ACCESSIBLE TO FREE FERR1TIN OR 
LABELED BY ANTI--SYNAPSIN I  IMMUNOEERRITIN:  Electronmicrographs 
of synaptosomal preparations labeled by immunoferritin and of synaptosomal 
preparations used for testing accessibility  to free ferritin were taken at random 
(magnifications as above), until a sample size of 200 nerve endings was reached 
for each of the two experimental conditions. Nerve endings were then divided 
into two groups, as indicated in the legend to Table I. 
RESULTS 
Synaptosomes Fixed in Nonlytic Conditions 
MORPHOLOGY:  Electron microscopic examination of the 
crude synaptosomal fraction, fixed under nonlytic conditions 
and embedded in agarose before processing for electron mi- 
croscopy, revealed  a  satisfactory retention  of ultrastructural 
morphology. The state of preservation of individual synapto- 
somes, however, was highly variable.  In the majority of syn- 
aptosomes the nerve ending showed a well-preserved structure 
("well-preserved  nerve  endings"):  vesicles  appeared  tightly 
packed in the terminal, coated vesicles were occasionally visi- 
ble,  the cytoplasm had  a  dense appearance,  and  the plasma 
membrane appeared continuous and intact (Fig. 2 a). In other 
synaptosomes the nerve ending was severely disrupted ("dis- 
rupted nerve endings"): the synaptic vesicles were quite dis- 
persed, the space between vesicles appeared clear (empty) with 
only a  few interconnecting fdaments, coated vesicles were in 
general not visible (see Discussion), and the plasma membrane 
was torn (often with one or more large interruptions visible in 
the  plane  of the  section)  (Fig.  2b).  The morphology of the 
disrupted  nerve  endings  suggested  that  their  plasma  mem- 
branes either had not resealed during homogenization, or that 
they had become leaky at some time before fixation, thereby 
allowing elution of cytosolic proteins in the solutions of low 
ionic strength used. 
The synaptic cleft was sometimes visible in the plane of the 
section. In such cases, the remnant of the postsynaptic com- 
partment  consisted of a  fragment of plasma membrane with 
the associated PSD. This plasma membrane fragment generally 
had free ends (e.g., Fig. 2 a) but in some cases appeared to have 
resealed to form a closed compartment (Fig. 2 b) No relation- 
ship  was observed  between  the  state  of preservation  of the 
nerve  ending and  the morphology of the postsynaptic com- 
partment. 
IMMUNOFERRITIN  LABELING:  when  synaptosomes 
ftxed in nonlytic conditions were immunolabeled by an indirect 
(36) immunoferritin procedure using control IgG (Rb) followed 
by  F-anti-IgG  (G  vs.  Rb),  only  scattered  ferritin  particles, 
isolated or in small clusters, 2 were observed on the subcellular 
particles  present  in  the  preparation  (Fig.  2a  and  b).  These 
ferritin particles were in general localized on the cytoplasmic 
faces of membranes, and, in particular, where these membrane 
2 Given the observation that only one ferritin particle seemed to be 
associated with each goat anti-rabbit IgG molecule (see Materials and 
Methods), the occurrence of background labeling by small clusters of 
ferritin  particles may be attributable  to the  indirect immunoferritin 
procedure used. Thus, the small clusters of  ferritin particles may reflect 
microeomplexes of rabbit IgGs and goat anti-rabbit IgGs. 
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TABLE  I 
Irnmunolabeling and Ferritin Penetration 
Immunolabel-  Test for ferritin 
ing  penetration 
34 
66 
Immunolabeled 
Nonimmunolabeled 
Penetrated by  29 
ferritin 
Nonpenetrated by  71 
ferritin 
Comparison  between  percentages of nerve endings immunolabeled  by anti- 
synaosin  I immunoferritin  and nerve endings accessible to free ferritin  in the 
same synaptosomal  preparation  fixed in nonlytic conditions.  Agarose blocks 
used  for  the  two  experimental  conditions  were  obtained  from  the  same 
agarose gel. A  total of 200 nerve endings  were counted  for each of the two 
conditions.  Nerve endings defined as nonimmunolabeled  or as nonpenetrated 
by ferritin  were  those  containing  _<10 ferritin  particles.  In  almost  all  cases, 
nerve endings of these two groups did not contain any ferritin  particles  (e.g., 
see Figs. 2 c, 4, 6 d and 7 a). Immunolabeled  endings and endings penetrated 
by ferritin  contained,  in general,  a very high  number of ferritin  particles  (up 
to >1,000 in large terminals;  see Figs. 2 c, 3, 4, and 6 d). 
faces  appeared  to  be  lined  by  a  microfdamentous  web  of 
cytoplasmic proteins (e.g.,  Fig. 2a). This web probably non- 
specifically traps the probes used for immunolabeling. 
When anti-synapsin I IgG (Rb) was used at the first antibody 
step of the immunostaining procedure (step 3), heavy labeling 
of ferritin  particles  occurred inside  disrupted  nerve endings. 
Such heavy labeling was specific for disrupted nerve terminals 
(Fig.  2c).  Figs.  3  and  4  show  several  examples  of heavily 
labeled disrupted synaptosomes. As is clearly visible in these 
micrographs,  the overwhelming majority of ferritin  particles 
were associated with the cytoplasmic face of synaptic vesicles, 
while  other organelles,  including larger vesicular  structures, 
mitochondria, and plasma membranes of the terminals,  were 
unlabeled.  The  qualitative  and  quantitative  distribution  of 
ferritin  particles on membranes other than  those of synaptic 
vesicles was very similar to the background labeling observed 
in samples reacted with control IgG (Rb). 
Labeling seemed to occur equally on all vesicles and did not 
appear to correlate with their topological distribution within 
the terminal, in relation to the synaptic cleft. In those instances 
in which vesicle labeling was not homogeneous in different 
portions  of the  terminal,  labeling  intensity  appeared  to  be 
determined  by the  accessibility  of the  vesicle  membrane  to 
ferritin particles (see e.g., Fig. 4d). In some cases, when space 
was  available  around  a  vesicle,  ferritin  particles  formed  a 
"corona" around it (Fig. 3, circle). Such orderly decoration of 
the  vesicle  profde  was  observed  in  a  particularly  clearcut 
fashion on those occasional vesicles that appeared to have been 
moved  to  an  ectopic  site  as  a  result  of the  manipulations 
involved in preparing the fixed synaptosomal suspension (Fig. 
5). Presumably labeled antibodies have relatively free access to 
the  surface  of such  ectopic  synaptic  vesicles,  with  minimal 
steric  hindrance  by neighboring  vesicles  and/or  connecting 
bridges  of cytoskeletal proteins.  When the corona was com- 
posed of a single "chain" of ferritin particles aroundthe vesicle, 
the ferritin particles were at a  distance of -115  A  from the 
outer leaflet of the vesicle membrane.  This distance of 115 A 
could be accounted for by two IgG molecules and the apofer- 
ritin shell around the electron-opaque iron core of the ferritin 
molecule (1, 37). Thus, the location of the ferritin particles is 
compatible  with  the  synapsin  I  antigenic  sites  being  either FIGURE  2  Electron micrographs illustrating morphology and immunoferritin labeling of synaptosomes fixed in nonlytic conditions 
and embedded in agarose. (a and  b) Synaptosomes from an agarose block that was incubated at the primary antibody step with 
control IgG (Rb). A well-preserved nerve ending is shown in a. Note the continuous plasma membrane, the tightly packed vesicles, 
and the dense cytoplasmic matrix between vesicles. Arrowheads indicate the synaptic cleft. A disrupted nerve ending is shown in 
b.  Large interruptions  are visible  in  the  plasma  membrane,  and  synaptic vesicles are dispersed  in  a  light  (empty)  matrix. The 
postsynaptic compartment  is  marked  by an  asterisk.  (c)  Synaptosomes from  an  agarose block that  had  been incubated  at the 
primary antibody step with  anti-synapsin  I  IgG  (Rb).  Prominent labeling by ferritin  particles is present on synaptic vesicles of a 
disrupted nerve ending (hi).  Note in this terminal the absence of labeling on mitochondria (m), on the plasma membrane (pm) 
of the nerve ending, and on vesicular structures different from synaptic vesicles (arrows). Adjacent well-preserved nerve endings 
(N *), which have an apparently sealed plasma membrane, are unlabeled. Synaptic clefts are indicated by arrowheads, a, x  72,500; 
b, x  58,500;  c, x  77,500. 
immediately  adjacent  to  the  vesicle  membrane  or  at  some 
distance  from  the  outer  leaflet  of the  membrane.  A  small 
percentage of ferritin  particles were visible at a  considerable 
distance  from  synaptic  vesicles.  This  distance  could  be  ex- 
plained either by the formation of small clusters of antibody 
and  antibody  conjugates,  given  the  indirect  nature  of our 
immunolabeling procedure, or by the presence of vesicles out 
of the plane of the section. 
A morphometric analysis of anti-synapsin I immunoferritin 
labeling in synaptosomes fLxed in nonlytic conditions, and not 
permeabilized  with detergent,  is shown in Fig. 6, columns a 
and d. The ratio of the total number of ferdtin particles to the 
total number of  vesicle profiles in random samples of 100 nerve 
endings is presented. The figure shows a remarkable difference 
between  the  labeling  of disrupted  nerve  endings  in samples 
reacted  with  control  IgG (Rb)  or  anti-synapsin  I  IgG  (Rb) 
respectively. The great variability ~n intensity of ferdtin label- 
ing in disrupted nerve endings (Fig. 6, column at) is probably 
due  to variations  in their  accessibility to the label.  Thus,  in 
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general, the highest ferdtin/vesicle ratios were found in those 
nerve endings with the smallest vesicle/area ratio (see Materials 
and Methods),  i,e.,  in those nerve endings in which synaptic 
vesicles  were  most highly dispersed  (not  shown).  When the 
whole profile of a vesicle in the plane of the section appeared 
to be freely accessible to marker proteins, as many as 40 ferdtin 
particles were sometimes counted around the vesicle.  It is also 
evident  from  Fig.  6  (columns a  and  d)  that  well-preserved 
nerve endings were not labeled. This raised the possibility that 
this  subpopulation  of nerve  endings  was  not  accessible  to 
antibodies  and antibody-conjugates due to the presence of a 
sealed plasma membrane. 
To determine if this was the case, we carried out an experi- 
ment  to test  for the  accessibility of synaptosomes to ferritin 
particles (see Materials and Methods). Agarose blocks, contain- 
ing synaptosomes fixed in nonlytic conditions, were incubated 
in the presence of  a high concentration of  unconjugated ferdtin 
and then  subjected to a  second fixation with glutaraldehyde 
while still in the ferritin-containing buffer. We found that while 
5ynapsin I: Nerve Terminal- Specific Phosphoprotein.  II.  1359 the disrupted nerve endings contained many ferritin particles 
(not shown), no ferritin was present inside the well-preserved 
nerve endings (Fig. 7).  A  comparison of percentages of nerve 
endings (a) not  accessible to ferritin and (b) unlabeled after 
anti-synapsin  I  immunolabeling in  two  agarose  blocks  ob- 
tained from the same agarose gel indicated that the unlabeled 
terminals in  the  immunocytochemical experiments could  be 
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accounted for by the inaccessibility  of the synaptosomes to the 
marker molecules (Table I). This result was highly suggestive 
of an ubiquitous presence of synapsin I in nerve terminals, but 
did not exclude the possibility that the inaccessible terminals 
constituted a  different population of nerve endings not con- 
t~ining synapsin I. To establish whether the inaccessible nerve 
endings, too, contained synapsin I, we next studied the effect FIGURES  3  and  4  Gallery  of  disrupted  nerve endings  from  synaptosomal  preparations fixed  in  nonlytic  conditions,  agarose- 
embedded,  and  labeled for  synapsin  I  by  immunoferritin.  The  large majority of  ferritin  particles  are  associated  with  synaptic 
vesicles.  In  Fig.  3,  ferritin  particles can  be seen forming  a  "corona"  around  a  vesicle  (black circle).  Mitochondria  (m),  plasma 
membranes (pm),  and vesicular structures other than synaptic vesicles  (arrows)  are unlabeled by the ferritin  particles. At  least 
some of the ferritin  particles apparently not contiguous to synaptic vesicles might be associated with vesicles out of the plane of 
the section. Note in  Fig. 4 d  the uneven distribution  of ferritin  particles. They are more abundant on those vesicles close to the 
large plasma  membrane discontinuity  and,  therefore,  more easily  (directly)  accessible  to  the  incubation  medium,  v, Synaptic 
vesicles artifactually relocated outside the nerve endings.  N ", Well-preserved  nerve ending,  not  labeled by ferritin,  cv,  Coated 
vesicles,  am,  Agarose matrix. Synaptic clefts are indicated by arrowheads. Fig. 3, x  140,000_ Fig. 4 ,~, X  104,000;  b, x  104,000;  c, x 
108,000;  d, X  104,000. 
of procedures aimed at damaging the integrity of the plasma 
membranes on subsequent immunolabeling. 
IMMUNOFERRITIN  LABELING  AFTER  PERMEABILIZA- 
TION  TREATMENTS"  Procedures  designed to  permeabilize 
the synaptosomal plasma membrane were carried out either on 
the fixed synaptosomal suspension before agarose embedding 
(freeze-thawing cycles) or on the synaptosome-containing aga- 
rose blocks (nonionic detergents). WeU-preserved nerve end- 
ings were  still recognizable after such  manipulations by the 
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dense appearance of their cytoplasm. Some of them showed a 
moderate degree of labeling, but the majority, even after in- 
cubation  with  high  concentrations  of detergents,  were  still 
poorly labeled or not labeled at all. Some examples of synap- 
tosomes  immunolabeled  after  pretreatment  with  saponin  or 
with Triton X-100 are shown in Fig. 8. Fig. 6, columns b  and 
e show the morphometric analysis of one of these experiments. 
Parallel experiments carried out to test the accessibility of the 
cytoplasm of well-preserved nerve endings to free ferritin after 
5ynapsin I: Nerve  Terminal- 5peofic Phosphoprotein.  II.  1361 FIGURE  5  Specific decoration of synaptic vesicles by 
anti-synapsin I immunoferritin. The micrographs were 
obtained  from  agarose  blocks  containing  synapto- 
somes  fixed in  nonlytic conditions. The two synaptic 
vesicles shown have leaked out of nerve endings and 
appear to  have been cross-linked  by the fixation  to 
other vesicular structures.  Free synaptic vesicles  (not 
cross-linked to other structures)  were never observed 
in our preparations. We assume that, due to their small 
size, they were not retained by the agarose meshwork. 
a and  b, x  220,000. 
FIGURE  6  Morphometric  analysis  of  immunoferritin  labeling  of  nerve  endings  processed  according  to  various  experimental 
procedures. Synaptosomal preparations were fixed either  in  nonlytic or  in  lytic conditions,  agar-embedded, incubated  in  the 
absence or presence of 0.5% saponin, and then immunoferritin-labeled. Control IgG  (Rb) or anti-synapsin I IgG (Rb) was used at 
the primary antibody step of the immunolabeling. For EM analysis,  randomly taken micrographs, including 100 nerve endings for 
each experimental condition, were used.  Nerve endings were grouped into two major classes (well-preserved nerve endings or 
disrupted nerve endings) according to the following characteristics: well-preserved nerve endings were those with  a continuous 
plasma membrane and a dense appearance as indicated either by the close apposition of synaptic vesicles,  or by the presence of 
a dense cytoplasmic matrix, or by both. They are represented in the figure by solid circles.  Disrupted nerve endings were those 
with a clear (empty) cytoplasm and dispersed vesicles.  They are represented in the figure by open circles.  The few nerve endings 
that were difficult  to classify (for instance, having an interrupted  plasma membrane but a rather dense cytoplasmic matrix)  are 
represented in the figure by open triangles. Clusters of free synaptic vesicles  that were not clearly part of a nerve ending remnant 
were not included in the count. The total number of ferritin  particles and the total number of synaptic vesicles  were counted for 
each nerve terminal. The ratios of these two numbers for individual nerve endings are presented in the figure. All values plotted 
in the stippled area are zeros.  Data reported in columns  A,  B,  D, and  E were obtained from four agarose  blocks cut out from  a 
single synaptosome-agarose gel. The two blocks used for the data reported in columns  C and  F were also obtained from a single 
gel. 
the detergent treatments indicated that a  large proportion of 
these endings were still poorly accessible or not accessible to 
free ferritin, even though their membranes had been permea- 
bilized (not shown).  Lack of immunolabeling or poor immu- 
nolabeling in these endings could, therefore, be attributed even 
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in  this  case to  poor penetration of marker molecules rather 
than to an absence of synapsin I. The lack of penetration by 
macromolecules, together with the  dense cytoplasmic matrix 
visible in these endings, suggests the presence of a tight network 
of fLxative-cross-linked cytosolic proteins.  Such  cross-linking FIGURE  7  Comparison of well-preserved nerve ending not immunolabeled after the immunoferritin procedure, with nerve ending 
not accessible to free ferritin.  (a)  Nerve ending from an agarose block subjected  to immunoferritin  labeling for synapsin  I.  (b) 
Nerve ending from an agarose block incubated in the presence of a high concentration of free ferritin and subsequently postfixed 
with glutaraldehyde while still  in the ferritin-containing  buffer.  (The few ferritin  particles visible inside the profile of the nerve 
ending  in  the  micrograph  [arrow]  are located  at the very periphery of  the ending,  in  a  region where the  plasmalemma is cut 
obliquely. The image, therefore, is compatible with the possibility that these ferritin particles are only apparently located inside the 
ending.) The agarose blocks used for  a and  b were from  the same agarose gel, which  contained synaptosomes fixed in nonlytic 
condition,  a and  b, x  100,000. 
appears to be closely associated with the preservation of good 
nerve ending morphology. 
Fig. 6, columns c andf. The data shown in this figure suggest 
that all nerve endings contain synapsin I. 
Synaptosomes  Fixed in Lytic Conditions 
MORPHOLOGY;  Since  optimal  ferritin  penetration  and 
heavy labeling  were  obtained  on  morphologically-disrupted 
terminals, we attempted to find fixation conditions that would 
result in a  disruption of all nerve endings. This was achieved 
by adding a large volume of hypotonic fixative solution at the 
final desired strength (3% formaldehyde, 0.5% glutaraldehyde, 
5 mM PB) to the crude synaptosomal fraction (lytic fixation). 
As seen by EM, all subcellular particles, and in particular nerve 
endings,  were  highly  disrupted  by  this  treatment  (Fig.  9). 
Synaptosomal  ghosts  were  stiU  recognizable  by  clusters  of 
synaptic vesicles that were contiguous to, and often partially 
enclosed by, fragments of  plasma membrane. In some cases the 
plasma membrane could be identified as part of a nerve ending 
by the  presence,  in  the  plane  of the  section,  of an adjacent 
PSD.  Clusters  of isolated synaptic vesicles,  apparently not in 
proximity to synaptosomal ghosts, were also visible.  The oc- 
currence of structurally well-preserved nerve endings in these 
preparations was extremely rare. 
IMMUNOFERRITIN LABELING;  When such preparations 
were immunolabeled for synapsin I  by the indirect immuno- 
ferritin procedure, a high concentration of  ferritin particles was 
always found at all sites  where vesicles or clusters of vesicles 
were present  (Fig. 9).  The large majority of ferritin particles 
decorated specifically the surface of synaptic vesicles.  The only 
unlabeled  vesicles were those present  in the rare,  apparently 
undamaged, nerve terminals. A quantitative analysis of ferritin 
labeling in synaptosomes fixed in lytic conditions is shown in 
Immunoferritin  Labefing of 5ynaptic Vesicles 
after Extraction  of 5ynapsin  I from  the Endings 
To further test the reliability of the immunoferritin method 
as a specific label for synapsin I, we applied it to a synaptosomal 
fraction previously processed by a  procedure designed to de- 
plete synaptosomes of synapsin I. The latter can be eluted from 
the surface of isolated synaptic vesicles by suspending them in 
a  large  volume  of 0.15  M  KC1 (20).  Therefore,  the  unfixed 
crude synaptosomal fraction was incubated in the presence of 
0.15 M KCI and 0.01% saponin. The rationale of the procedure 
was to open focal discontinuities in the plasma membrane by 
saponin (4, 31) and to extract synapsin I from its intracellular 
binding sites  by exposing it to a large volume of 0.15  M KC1; 
the focal discontinuities in the plasma membranes would then 
allow cytoplasmic proteins, including solubilized synapsin I, to 
be released into the medium. After the KCl-saponin incuba- 
tion, the synaptosomes were recovered by centrifugation, fixed, 
and  embedded  in  agarose.  Fig.  10  shows synaptosomes im- 
munolabeled for synapsin I after such treatment.  Discontinui- 
ties are visible in the plasma membranes of the endings and 
the cytoplasmic space of the endings appears rather "watery" 
(empty) as if most cytoplasmic proteins  had been eluted.  In 
spite of their apparent accessibility to marker molecules, syn- 
aptic vesicles are not labeled by ferritin.  The morphology of 
the two synaptosomes shown in Fig. 10 is representative of the 
morphology of the  bulk  of the  synaptosomes present  in the 
preparation. 
DE  CAMILLI ET AL.  Synapsin  I: Nerve  Terminal-Specific  Phosphoprotein.  II.  1363 FIGURE  8  Gallery of  nerve endings  from  a  synaptosomal  preparation fixed  in  nonlytic conditions,  embedded  in  agarose and 
immunolabeled  for  synapsin  I  after  saponin  (0.5%  [wt/vol])  treatment.  The  plasma  membranes  of  the  endings  disp[ay  the 
festooned  profiles  and  the focal  discontinuities  known  to  be  produced  by saponin  (4,  31).  The  nerve ending shown  in  a  is a 
disrupted  nerve ending, as can be seen from the space around vesicles which appears clear (except for the ferritin  particles), and 
from the large interruptions of the plasma membrane (arrows).  Nerve endings from  b  to  d  are characterized by an increasingly 
dense cytoplasmic matrix. Labeling is high in  a; present, but scanty, in  b; even more scanty in  c; and absent in  d, in reverse order 
to the apparent density of the cytoplasmic matrix,  a, x  92,000;  b, x  107,000;  c, x  101,000;  d, x'-'103,000. 
FIGURE  9  Distribution of anti-synapsin I immunoferritin in a synaptosomal preparation embedded in agarose after lytic fixation. 
Synaptosomes and mitochondria are severely disrupted. Mitochondria (m)  have the typical morphology observed after exposure 
to severe hypoosmotic conditions  (12).  Nerve endings (N)  are clearly open. Clusters of vesicles (v) apparently not in proximity to 
synaptosomal ghosts  are visible.  Postsynaptic densities are visible at the synaptic junctions  indicated  by arrowheads. Note the 
prominent labeling associated with synaptic vesicles. The large cluster of ferritin particles indicated by an arrow does not represent 
specific  labeling.  Images like this cluster were very rare and were also seen in  blocks  reacted with  control  IgG  (Rb)  at the first 
antibody  step.  They  may  represent  complexes  of  rabbit  IgGs  and  ferritin-conjugated  goat  anti-rabbit  IgGs  that  form  as  a 
consequence of a slow shedding of antibodies from antigenic sites,  x  68,000. 
1364  THE  IOURNAL OF  CELL BIOLOGY.  VOLUME 96,  1983 DE  CAMILLI  [T  AL.  Synapsin I: Nerve  Terminal-Specific Phosphoprotein.  II.  1~ FIGURE 10  Anti-synapsin I immunoferritin labeling of nerve endings after extraction of synapsin I by the saponin-KCI treatment. 
In the pictures the features characteristic of saponin-treated particles (4)  are visible: undulated and focally interrupted  plasma 
membranes and  ruptured  synaptic  vesicle membranes (arrows).  Note also the clear  (empty)  appearance of  the  space among 
vesicles, suggesting that most cytoplasmic proteins had been released from these endings before fixation,  rn,  Mitochondria. A 
synaptic cleft is indicated by an arrowhead, a, x  117,000;  b, x  116,000. 
Immunoferritin Labeling of PSDs 
Two previous studies (2, 39) had suggested that synapsin I 
might be present at PSDs.  Using the procedures developed in 
the  present  study,  we  have  reexamined  this  question.  Occa- 
sional ferritin particles were found to be associated with PSDs 
when they were not enclosed by a  sealed plasma membrane. 
Such  labeling,  however,  did  not  appear  to  be  significantly 
different  in  samples  reacted  with  control  IgG  (Rb)  or  with 
anti-synapsin  I  IgG (Rb) (Fig.  ll; compare also Fig. 2a with 
Fig. 2 c). This conclusion is supported by the quantitative data 
reported in Table II. 
Immunoperoxidase Staining of Agarose- 
embedded Synaptosomes 
Agarose-embedded synaptosomes fixed in either nonlytic or 
lytic conditions were also immunolabeled for synapsin I by an 
indirect (36) immunoperoxidase procedure (14). 
In  preliminary  experiments,  carried  out  with  control  IgG 
(Rb) at the fwst antibody step of the immunostaining procedure 
(step 3), a free coating by peroxidase reaction product (14,  36) 
was often found on all surfaces of subcellular particles exposed 
to the incubation  medium. We selected incubation times and 
concentrations  of reagents  for  the  peroxidase  reaction  that 
minimized this background (Fig.  12a). When rabbit anti-syn- 
apsin  I  IgG (Rb)  was used  at  the  first antibody step  of the 
immunoperoxidase procedure (step 3), a  specific, very promi- 
nent accumulation of  peroxidase reaction product was observed 
on disrupted nerve endings (Figs.  12b-d and  13). Peroxidase- 
positive terminals constituted  <50% of synaptosomal profiles 
observed after fixation under  nonlytic conditions,  while they 
accounted  for close to  100% of the total synaptosomal popu- 
lation  in  preparations  fixed under  lytic conditions  (Fig.  13). 
Reaction  product  was  not  present  in  well-preserved  nerve 
endings (Fig.  12 b and d). However, when plasma membranes 
were  made  permeable  by  saponin  or  freeze-thawing,  some 
apparently  well-preserved  nerve  endings  did  show  light  im- 
munoreactivity  (Fig.  12e).  Therefore,  results  obtained  using 
the  immunoperoxidase  procedure  were,  in  several  respects, 
identical to those obtained by the immunoferritin procedure. 
However,  in  one  respect  they  differed:  peroxidase  reaction 
product accumulated on all membranes directly contiguous to 
synaptic vesicles, irrespective of the nature of the membranes. 
Thus, reaction product was present on all cytoplasmic faces of 
membranes  of disrupted  nerve  terminals  and  also  on  mem- 
branes of other organelles present in the crude synaptosomal 
fraction, which in the process of fixation and agarose embed- 
ding had become contiguous to synaptic vesicles. Peroxidase 
labeling of membranes other than synaptic vesicle membranes 
was in  general concentrated  on the  region  of the  membrane 
nearest  to  and  facing synaptic vesicles and  was  absent  from 
portions  at  a  distance  from  the  vesicles.  Occasionally,  some 
small  membrane  fragments  apparently  not  in  proximity  to 
synaptic vesicles were specifically labeled by the reaction prod- 
uct  (Fig.  13).  However,  these  membranes  might  have  been 
close to synaptic vesicles out of the plane of the section. 
Immunoperoxidase Labeling of Intact Tissues 
In a previous immunoperoxidase study of the localization of 
synapsin I  in intact  tissues at the ultrastructural  level, it was 
possible to demonstrate reaction product in only a  small pro- 
portion of nerve endings (2).  Given the information obtained 
in the present study of isolated synaptosomes, we have reex- 
amined the immunolabeling of synapsin I  in intact tissue by 
EM, For this purpose we used thick (20/~m) frozen sections of 
fLxed brain tissue. Attempts to immunolabel nerve endings in 
these sections by immunoferritin failed because of the almost 
complete lack of penetration of ferritin into the sections, even 
1366  THE  IOURNAL  Of  CELL BIOLOGY  .  VOLUME  96,  1983 FIGURE 11  Comparison of ferritin  labeling of PSDs reacted with control IgG  (Rb)  (a and  c)  and anti-synapsin I IgG  (Rb)  (b and 
d), at the primary antibody step of the immunolabeling procedure. The micrographs were obtained from synaptosomes embedded 
in  agarose after nonlytic fixation. Scattered ferritin  particles are present on  all four  PSDs with  no apparent difference  between 
control  and  immune-treated synaptosomes. In  contrast, a  striking  difference  in  particle  labeling  is observed on  vesicles in  the 
nerve endings (disrupted nerve endings). Synaptic clefts are indicated by arrowheads, a, x  107,000;  b, x  110,000;  c, x  108,000;  d, 
x  106,000. 
TABLE  II 
Immunoferritin  Labeling 
Total 
number 
Number  Total  of ferritin 
of PSDs  length,  particles, 
counted  L  n  n/L 
#m 
Control  47  16.15  777  48.1 
Immune  53  16.14  923  57.2 
Quantitative comparison between immunoferritin  labeling  of PSDs reacted 
with control IgG (Rb) and anti-synapsin  I IgG (Rb) at the primary antibody 
step of the immunolabeling  procedure.  The morphometric  analysis  was carried 
out as described in Materials and Methods. 
after  incubation with  detergents.  In contrast, some  labeling 
could be obtained by the immunoperoxidase technique. Per- 
oxidase reaction product was detected only on nerve terminals 
(Fig. 14) and was confined to terminals of the most superficial 
portions of the thick sections. Furthermore, even in the super- 
ficial layers, it was  seen in only some nerve terminals. The 
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proportion of immunolabeled nerve terminals increased, but 
only to a limited extent, when the sections had been pretreated 
with detergent (saponin or Triton X-100) to permeabilize mem- 
branes before incubation with antibodies. 
In  both  detergent-treated  and  nontreated tissue  sections, 
those terminals that showed immtmoreactivity were labeled to 
a variable extent by the reaction product, which in many cases 
was unevenly distributed in the ending (Fig.  14). Tears were 
often visible in those terminals or portions of terminals that 
were heavily stained (Fig. 14 a). 
The distribution of peroxidase reaction product in the cyto- 
plasm  of the  terminal was  very  similar to  the  distribution 
observed  in  immunoperoxidase-reacted,  agarose-embedded 
isolated  synaptosomes.  Thus,  reaction  product,  rather  than 
being confined to  a  specific  structure  of the  nerve ending, 
occupied the whole cytoplasmic space, and labeled cytoplasmic 
faces of axon terminal membranes irrespective of their nature. 
DISCUSSION 
The aim of this study was to determine, at the ultrastructural 
level, the localization of synapsin I in synapses and the pro- 
Synapsin I: Nerve Terminal-Specific Phosphoprotein.  II.  "~  367 FIGURE 12  Immunoperoxidase staining for synapsin I of synaptosomes embedded in agarose after nonlytic fixation. (a) Disrupted 
nerve  ending  from  an  agarose block  incubated  with  control  IgG  (Rb)  at  the  primary antibody  step  of  the  immunostaining 
procedure. Low level background labeling by peroxidase reaction product is visible on some membranes exposed to the incubation 
medium, in  particular plasma membranes (arrows). Some increase in density of the PSD is also visible.  (b-d)  Disrupted  nerve 
endings (N) and well-preserved nerve endings (N *) from synaptosomal preparations incubated with anti-synapsin I IgG (Rb)  at 
the primary antibody step of the immunolabeling procedure. Reaction product darkens synaptic vesicle membranes and all other 
membranes (e.g.,  presynaptic plasma membranes) exposed to the cytoplasmic space of the disrupted endings. Staining appears 
more prominent when vesicles are more dispersed (b and  c) than when they are more densely packed (d). In the latter case, the 
reaction product is homogeneously distributed in the space among vesicles. Well-preserved nerve endings are unlabeled. (e) The 
nerve ending labeled  N * °  is from an agarose block containing synaptosomes permeabilized by freeze-thawing before agarose- 
embedding. It shows a compact structure and is only partially and unevenly labeled by peroxidase. Some background labeling on 
membranes exposed to the incubation medium is visible in  b-e. This is similar in intensity to the background labeling observed 
on membranes in a. Synaptic clefts are indicated by arrowheads; m, mitochondria. Micrographs shown in b- e are from thin sections 
not stained by uranyl acetate and lead citrate, a, x  47,500;  b, x  40,500;  c, 45,000;  d, x  62,000;  e, x  53,000. 
portion of synapses at which synapsin I is present. To answer 
these questions we have developed an EM technique to label 
isolated  synaptosomes embedded  in  agarose.  Synaptosomes, 
which can be prepared easily from the central nervous system, 
contain the relevant elements of the synapse: the resealed nerve 
ending and the postsynaptic membrane with the attached PSD. 
Synaptosomes are, therefore, a suitable model system in which 
to study the localization of macromolecules in the architecture 
of the synapse. Our results indicate that synapsin I is specifi- 
cally associated with synaptic vesicles and that it is present on 
vesicles of  the great majority of  (and possibly all) nerve endings. 
Advantages of Agarose-embedded 
Synaptosomes over Tissue Sections as an 
Experimental Model 
Immunolabeling of synaptosomes embedded in agarose of- 
fers  three  important  advantages  over traditional  methods  to 
immunostain  antigens  in synapses, which involve the use of 
fLxed tissue sections: (a) prefixation manipulations and fixation 
can be performed under precisely defined conditions on iso- 
luted  synaptosomes. This possibility to manipulate  the  cyto- 
plasmic matrix of the nerve endings by appropriate treatments 
before and during the fixation proved to be very useful in our 
study.  (b)  Synaptosomes are  spatially  separated  from other 
structures and from each other by the meshwork of  the agarose. 
All  synaptosomes are,  therefore,  easily  accessible  to marker 
proteins (even to large probes such as ferritin-conjugated anti- 
bodies),  which diffuse freely through the  agarose matrix.  (c) 
Agarose embedding of synaptosomes allows subsequent han- 
dling of the synaptosomes in the agarose blocks in a manner 
similar to that used for tissue specimens. This avoids synapto- 
somal losses or damages expected to occur upon the repeated 
sedimentation/resuspension  steps otherwise needed to accom- 
plish immunolabeling. 
Role of the Fixation Procedure in Synapsin 
i Immunostaining 
Satisfactory immunostaining of synapsin I in nerve endings 
was obtained only when the majority of the cytoplasmic pro- 
teins had been extracted. The importance of the meshwork of 
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Subcellular particles are highly deformed and disrupted. Mitochondria (m) have the typical concave shape observed after severely 
hypotonic fixation  (12).  All  recognizable synaptic vesicles are labeled, irrespective of their localization (within or outside nerve 
ending remnants [ N]). Reaction product also decorates membrane fragments adjacent to synaptic vesicles (arrows) and occasionally 
membrane fragments apparently not in proximity to synaptic vesicles,  v, Free clusters of synaptic vesicles; M, remnant of myelin 
sheaths, x  17,000. 
the aldehyde-cross-linked cytoplasmic proteins as a barrier to 
the  diffusion of marker  macromolecules is  well known,  and 
several methods have been developed to reduce this meshwork 
to a minimum (17,  31, 40).  In our case this was accomplished 
by selectively extracting from the terminals those proteins that 
are  soluble  in  low  ionic  strength.  Under  low  ionic  strength 
conditions, synapsin I is known to remain quantitatively asso- 
ciated with membranes (20). 
When nerve endings were fixed in isotonic sucrose,  heavy 
labeling could be observed on disrupted nerve endings but not 
on well-preserved nerve endings. In spite of the large interrup- 
tions often visible in the plasma membrane of disrupted nerve 
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endings, a large number of vesicles were still  present, presum- 
ably connected by a cytoskeletal network not disrupted by the 
low ionic strength medium. 
Prominent labeling of practically all terminals was achieved 
only when all nerve endings were made leaky by hypoosmotic 
shock before fixative action. Resuspending the synaptosomes 
in a  large volume of 1 ×  fixative solution, in the absence of 
sucrose, proved an effective way of  acoomplishing a generalized 
lysis of nerve endings.  Since this occurred almost simultane- 
ously  with  the  fixation,  the  essential  features  of the  nerve 
ending morphology were preserved. The fixative solution used 
(1 M  formaldehyde, 0.05  M  gluteraldehyde, 5 mM phosphate 
Synapsin I: Nerve Terminal- Specific Phosphoprotein.  II.  1369 FIGURE 14  Immunoperoxidase labeling of synapsin I in frozen sections of rat brain. Frozen  sections (20/~m  thick)  of fixed brain 
tissue were stained in suspension by the immunoperoxidase labeling procedure and subsequently processed for EM.  (a and  b) 
Brainstem motor nucleus. The micrographs show coexistence of labeled (for instance,  N1- N5 in a and  Nlo in b) and unlabeled (for 
instance,  Ne-N8  in  a and  N~  in  b) terminals in the same field.  N9 is a nerve ending labeled only in one portion, n, Nucleus; a, 
myelinated axons. (c) Mossy fiber terminal (mf) in the granule cell layer of the cerebellum. Peroxidase reaction product is unevenly 
distributed in the ending,  d, Dendrites. All micrographs shown in this figure are from experiments in which detergent treatments 
were not included in the immunostaining protocol, a and  b were taken from thin sections not stained by urany[ acetate and lead 
citrate,  a, X 31,000;  b, x  41,000;  c, x  40,000. 
1370 buffer)  was  strongly  hypoosmotic,  since  formaldehyde  and 
glutaraldehyde diffuse rapidly through biological membranes 
and,  therefore,  do not contribute  to estabhshing  an osmotic 
gradient (12). As formaldehyde was the predominant aldehyde 
component of the fixative mixture, and since the cross-linking 
action  of formaldehyde proceeds  very slowly (12),  it  is  not 
surprising that a  severe disruption  and extraction of the ter- 
minals takes place before cross-linking occurs. 
Distribution of the Ferritin Label 
in Synaptosomes 
In immunolabeled disrupted nerve endings, an overwhelm- 
ing majority of ferritin particles were associated with synaptic 
vesicle membranes.  Very few ferritin particles were observed 
to be associated with other membranes. In those well-preserved 
nerve  endings  that  were  labeled  with  ferritin  particles  after 
treatments that permeabilize plasma membranes, labeling was 
so scanty that it did not allow any conclusion concerning the 
distribution of synapsin I. 
The necessity to partially disrupt the molecular architecture 
of the cytoplasm of  the terminals in order to obtain a substantial 
degree of labeling raises important questions concerning the 
physiological significance of our immunocytochemical locah- 
zation. This issue of physiological significance also arises when 
one  considers  that,  to  prevent  elution  of synapsin  I  upon 
disruption of the plasma membrane, the cytoplasmic space of 
the nerve ending had to be exposed to solutions of low ionic 
strength. In the presence of 150 mM KC1 (i.e.,  approximately 
the ionic strength  of the cytoplasm), synapsin I  was rapidly 
solubilized from terminals with a leaky plasma membrane (Fig. 
10). 
A  redistribution of synapsin I in nerve endings upon expo- 
sure to low ionic strength cannot be excluded.  However, two 
considerations suggest that the localization of synapsin I on the 
vesicle membrane does indeed reflect its localization in vivo. 
(a)  The very specific localization  of synapsin  I  on  synaptic 
vesicle  membranes  and  not  on other membranes  suggests  a 
specific interaction rather than a nonspecific absorption occur- 
ring upon nerve ending disruption. (b) Light microscopic stud- 
ies (2, 8, 9) and EM studies in tissue sections (2; and the present 
study) clearly show that synapsin I  is concentrated in nerve 
endings.  Such compartmentalization of synapsin I (a protein 
of the cytoplasmic space)  must be interpreted  in terms  of a 
strong  interaction  with  the  equivalent  of a  solid  substrate 
(membrane or cytoskeleton) present in nerve endings. Synaptic 
vesicles,  which are highly concentrated in nerve endings, ap- 
pear  as  an  attractive  candidate  to be  the  binding  site.  This 
matter is further discussed in the third paper of this series (20). 
Several technical limitations prevent using the immunofer- 
ritin results to estimate the number of synapsin I molecules on 
individual vesicles in vivo. These limitations include the indi- 
rect  nature  of the  immunolabeling  procedure,  the  variable 
accessibility of the synaptic vesicle surface, and  the possible 
loss of antigenicity of some synapsin I molecules. However, the 
presence  in  some  nerve  endings  of as  many  as  40  ferritin 
particles/vesicle (Fig. 6, columns d-f),  and images like those 
shown  in  Fig.  5,  suggest  that  more  than  a  few  synapsin  I 
molecules are present  on each  vesicle.  This  interpretation  is 
also supported by the very high concentration of synapsin I 
found in the nervous system and by the proportion (-6%) of 
the total synaptic vesicle protein represented by synapsin I (20). 
Ferritin vs. Peroxidase 
The results obtained by the immunoperoxidase procedure in 
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agarose-embedded synaptosomes confirmed the immunoferri- 
tin data concerning the presence of synapsin I immunoreactiv- 
ity  in  nerve  endings  and  the  proportion  of nerve  endings 
showing positive immunoreactivity under various experimental 
conditions. The immunoperoxidase results,  like the immuno- 
ferritin results, suggested the presence of synapsin I in all nerve 
endings. Peroxidase reaction product, however, did not exhibit 
the same specific localization. A  detailed examination of the 
micrographs of peroxidase-stained  preparations  supports the 
idea  that this  less  specific localization is due  to the indirect 
nature  of the labeling,  which allows  stain  to occur at  some 
distance from the peroxidase molecule  (30).  Thus,  (a) mem- 
branes in close proximity to synaptic vesicles were frequently 
darkened,  irrespective  of their  nature,  and  (b)  in  many in- 
stances,  such  darkening  was  limited  to  the  portions  of the 
membranes closest to the synaptic vesicles. 
An alternative explanation for the discrepancy between the 
immunoferritin  and  the immunoperoxidase  results  might be 
that  the  synapsin  I  molecules  not  on  synaptic  vesicles  are 
partially shielded by a web of other proteins and are accessible 
to  the  smaller  peroxidase-IgG  conjugate  but  not  the  larger 
ferritin-IgG conjugate.  Arguing against this possibility, how- 
ever, we found that no major web was visible on the cytoplas- 
mic faces of certain membranes heavily stained by peroxidase 
but not by ferritin,  such as for instance, mitochondrial outer 
membranes and the nonjunctional portion of the nerve-ending 
plasma membranes. 
The distribution of the peroxidase reaction product, seen in 
isolated  nerve endings upon immunoperoxidase  labeling  for 
synapsin I, is very similar to the one seen in fLxed brain slices 
after the same labeling protocol. This pattern (staining of all 
membranes exposed to the cytoplasmic space) seems to be a 
common pattern for proteins located in the cytoplasmic space 
of the  terminal  (the  space  not  included  within  membrane- 
bound organelles), irrespective of their precise subcellular lo- 
calization. Thus, a similar distribution of peroxidase reaction 
product has been observed after staining for clathrin (6),  for 
the 65,000-dalton protein (a synaptic vesicle membrane pro- 
tein)  (27),  and for proteins specific to certain  terminals  and 
thought to be soluble, such as tyrosine hydroxylase (33),  glu- 
tamate decarboxylase (34, 41), and cGMP-dependent protein 
kinase (unpubhshed  results).  The similarity of these patterns 
indicates that the peroxidase reaction product accumulates in 
the whole cytoplasmic space and  is then nonspecifically ad- 
sorbed onto any nearby particulate  structure,  irrespective  of 
the subcellular localization of a given protein in the cytoplasm 
of the terminal. 
Immunocytochemistry in Tissue Sections 
Immunocytochemistry in tissue sections at the ultrastructural 
level confirmed the specific localization of synapsin I in nerve 
endings.  Labeling  of intact  tissue,  however,  appeared  to be 
greatly hampered  by poor penetration  of marker molecules. 
The tissue was totally inaccessible to ferritin-conjugated pro- 
teins.  After peroxidase  staining,  only a  minor proportion of 
nerve  endings  were  labeled  even  after  treatments  aimed  at 
permeabilizing plasma membranes. 
Similar results were obtained in a previous immunoperoxi- 
dase study carried out on vibrotome sections (2). Our results in 
isolated  synapses indicate  that  the uneven labeling in tissue 
sections, observed in that study (2)  and in the present study, 
may be artifactual. The erratic labeling is most likely dependent 
on an uneven diffusion of marker proteins in the neuropile, 
which, in turn, might be dependent on an uneven fixation. 
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were most heavily stained.  These ruptures  might have been 
present  before the staining (and have been  at least partially 
responsible for the good staining) or might have been produced 
by the process  of polymerization of the peroxidase  reaction 
product.  In either ease, they seem to be the expression of an 
incomplete cross-linking of the cytoplasmic matrix. Nonstained 
terminals showed, in general, a very well preserved morphol- 
ogy. 
Imraunoperoxidase labeling of nerve terminals in thick sec- 
tions of brain before Epon embedding is a widely used tech- 
nique to identify and sometimes to quantitate specific types of 
synaptic inputs in brain regions (36). Our results indicate that 
caution should be used in the interpretation of data obtained 
by this approach. Even if the proportion of terminals accessible 
to macromolecules were higher with fuxation conditions differ- 
ent from ours, it is important to consider the possibility that 
some of the terminals are unstained because they are inacces- 
sible to the marker molecules. 
PSDs 
In an earlier  study,  Synapsin  I  immunoreactivity was ob- 
served at some PSDs facing labeled terminals (2). Similarly, in 
the  present  study,  ferritin  particles  and  peroxidase  reaction 
products were often present on PSDs in immunolabeled sam- 
pies.  However, such labeling was quantitatively similar to that 
observed in control samples. NonspeciIic labeling of PSDs is 
probably the result of a nonspecific trapping of marker mole- 
cules in the fdamentous meshwork of the PSDs. 
In  tissue  sections  not  treated  with  detergents,  we  never 
observed immunoperoxidase reaction product on PSDs, even 
when PSDs were close to the free surface of the frozen section 
and no intervening membranes were visible between the PSD 
and  the surface of the frozen section.  A  slight darkening of 
PSDs,  which  occurred  exclusively  at  synapses  with  heavily 
labeled terminals, was observed only in sections that had been 
pretreated with detergents. Labeling of PSDs, therefore, seems 
to be an artifact due to diffusion of reaction product from the 
nerve ending,  the diffusion occurring when the permeability 
barrier represented by intact membranes is abolished. 
Synapsin I and Synaptic Vesicle Function 
The specific association of synapsin I with synaptic vesicles 
in the majority of, and possibly in all, nerve endings indicated 
by the  present  study suggests  that  the  role  of synapsin  I  is 
related to some aspect of the function of synaptic vesicles and, 
therefore,  directly  or indirectly,  to  the  primary  function  of 
nerve endings, which is the vesicular release (via exocytosis) of 
neurotransmitter. The ability of synapsin I to act as a substrate 
for cAMP- and Ca/calmodulin-dependent  protein kinases in 
broken cell preparations and in physiological conditions (10, 
18, 19, 29, 35) makes this protein a candidate to be involved in 
regulation of the release process itself,  since this process can be 
regulated both by Ca (5, 22) and by cAMP (3, 24, 28). 
Given  the  localization  of synapsin  I  at  the  cytoplasmic 
surface  of synaptic  vesicles,  an  attractive  hypothesis  is  that 
synapsin I might mediate a  specific interaction(s) of synaptic 
vesicles with other subeellular elements (e.g., cytoskeletal pro- 
teins  or  plasma  membrane  proteins).  The  observation  that 
synapsin  I  is  associated  with  the  vesicle  membrane  via  an 
electrostatic  interaction  (20)  raises  the  possibility  that  this 
association might not be permanent but limited to some stage(s) 
of the vesicle cycle in the nerve ending (storage, translocation 
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to the plasma membrane, fusion with the plasma membrane, 
retrieval from the plasma membrane). 
The experimental results obtained in the present study allow 
us to conclude only that synapsin I is associated with synaptic 
vesicles  during  their  storage  phase  in  the  cytoplasm of the 
nerve ending. Ferritin particles were never observed unambig- 
uously decorating the cytoplasmic face of the plasma mem- 
brane of the ending. However, the region of the nerve terminal 
plasmalemma at which synaptic vesicles fuse (i.e., the region of 
the presynaptic plasmalemma directly facing the synaptic cleft) 
was often lined by a web of cytoplasmic matrix and by tightly 
packed synaptic vesicles (see, for instance, Figs. 3, 4, and 11). 
Lack of labeling of this region, therefore, might be due to lack 
of accessibility to marker molecules rather than to absence of 
synapsin I. 
It has been proposed that patches of synaptic vesicle mem- 
branes  incorporated  into the plasmalemma  upon fusion  are 
recovered as coated vesicles (16). Therefore, it would be helpful 
to know if coated vesicles contain synapsin I. Unfortunately, 
conditions required  to obtain optimal labeling of synapsin I 
(permeabilization  of the plasma membrane and exposure of 
the cytoplasmic space to a large volume of low ionic strength 
medium) lead to a disappearance of coated vesicles.  Thus, as 
can be seen in Figs. 2-4, coated vesicles were only visible in 
well-preserved endings, i.e.,  those poorly accessible to immu- 
nolabeling.  This  is  in  agreement  with  our  observation  that 
clathrin, the constituent of the coat (32), is solubilized by low 
ionic strength buffers at neutral pH (20). 
Experiments are in progress to elucidate those stages of the 
synaptic vesicle cycle in the nerve ending during which syn- 
apsin  I  is associated with the vesicle membrane.  This  infor- 
mation is expected to be very important for the identification 
of the function of this protein. 
Clearly, much further work is needed to achieve an under- 
standing of the precise role played by synapsin I in the function 
of synaptic vesicles.  One important clue, however, exists:  al- 
though synapsin I is present in virtually all nerve endings, it 
appears to be absent from nonneuronal secretory cells (8, 9). 
This indicates that synapsin I is involved in some aspect(s) of 
regulation of vesicular secretion specific to neurons rather than 
in those steps of vesicular secretion that are common to neu- 
ronal and nonneuronal secretory systems. 
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